134 related articles for article (PubMed ID: 38217846)
21. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection.
Killgore KM; March KL; Guglielmo BJ
Ann Pharmacother; 2004; 38(7-8):1148-52. PubMed ID: 15150380
[TBL] [Abstract][Full Text] [Related]
22. Frequency and Antibiotic Resistance of Bacteria Implicated in Community Urinary Tract Infections in North Aveiro Between 2011 and 2014.
Costa T; Linhares I; Ferreira R; Neves J; Almeida A
Microb Drug Resist; 2018 May; 24(4):493-504. PubMed ID: 28922100
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of community origin of major multidrug-resistant ESKAPE uropathogens in a paediatric population in South-East Gabon.
Mouanga-Ndzime Y; Onanga R; Longo-Pendy NM; Bignoumba M; Bisseye C
Antimicrob Resist Infect Control; 2023 May; 12(1):47. PubMed ID: 37173760
[TBL] [Abstract][Full Text] [Related]
25. Pediatric community acquired urinary tract infections due to extended-spectrum beta-lactamase versus non-extended-spectrum beta-lactamase producing bacteria.
Alsubaie MA; Alsuheili AZ; Aljehani MN; Alothman AA; Alzahrani AS; Mohammedfadel HA; Alnajjar AA
Pediatr Int; 2023; 65(1):e15620. PubMed ID: 37735838
[TBL] [Abstract][Full Text] [Related]
26. [Investigation of Virulence Factors, Phylogenetic Group Features, and the Presence of ST131 Clone in Escherichia coli Isolates, a Urinary Tract Infection Agent in Children].
Kılıç SG; Öcal D; Tekeli A; Dolapçı İ
Mikrobiyol Bul; 2023 Oct; 57(4):535-552. PubMed ID: 37885384
[TBL] [Abstract][Full Text] [Related]
27. [National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients].
Wagenlehner FM; Schmiemann G; Hoyme U; Fünfstück R; Hummers-Pradier E; Kaase M; Kniehl E; Selbach I; Sester U; Vahlensieck W; Watermann D; Naber KG
Urologe A; 2011 Feb; 50(2):153-69. PubMed ID: 21312083
[TBL] [Abstract][Full Text] [Related]
28. Contemporary Evaluation of Tebipenem
Mendes RE; Arends SJR; Streit JM; Critchley I; Cotroneo N; Castanheira M
Microbiol Spectr; 2023 Feb; 11(1):e0205722. PubMed ID: 36625644
[TBL] [Abstract][Full Text] [Related]
29. In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010.
Sanchez GV; Master RN; Karlowsky JA; Bordon JM
Antimicrob Agents Chemother; 2012 Apr; 56(4):2181-3. PubMed ID: 22252813
[TBL] [Abstract][Full Text] [Related]
30. Urinary Tract Infections in Long-term Care: Evaluation of Uropathogens, Antibiotic Susceptibility, and Empiric Treatment.
Bao W; Koro M; Loh GW; Ortiz A
Sr Care Pharm; 2022 Jun; 37(6):232-243. PubMed ID: 35610764
[No Abstract] [Full Text] [Related]
31. Antimicrobial resistance of gram-negative bacteria: A six-year longitudinal study in a hospital in Saudi Arabia.
Al-Tawfiq JA; Rabaan AA; Saunar JV; Bazzi AM
J Infect Public Health; 2020 May; 13(5):737-745. PubMed ID: 32008927
[TBL] [Abstract][Full Text] [Related]
32. A cost-minimization analysis of treatment options for postmenopausal women with dysuria.
Bradley MS; Beigi RH; Shepherd JP
Am J Obstet Gynecol; 2019 Nov; 221(5):505.e1-505.e7. PubMed ID: 31055032
[TBL] [Abstract][Full Text] [Related]
33. Antibiogram of uropathogens and associated risk factors among asymptomatic female college students in Dessie town, Northeast Ethiopia.
Reda BK; Molla G; Gedefie A; Gebretsadik D; Tilahun M; Belete MA; Shibabaw A
PLoS One; 2023; 18(11):e0276033. PubMed ID: 38019765
[TBL] [Abstract][Full Text] [Related]
34. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model.
Vellinga A; Tansey S; Hanahoe B; Bennett K; Murphy AW; Cormican M
J Antimicrob Chemother; 2012 Oct; 67(10):2523-30. PubMed ID: 22729920
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic treatment failure of uncomplicated urinary tract infections in primary care.
Koh SWC; Ng TSM; Loh VWK; Goh JC; Low SH; Tan WZ; Wong HC; Durai P; Sun LJ; Young D; Tambyah PA
Antimicrob Resist Infect Control; 2023 Aug; 12(1):73. PubMed ID: 37528415
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial resistance in women with urinary tract infection in primary care: No relation with type 2 diabetes mellitus.
Vinken JEM; Mol HE; Verheij TJM; van Delft S; Kolader M; Ekkelenkamp MB; Rutten GEHM; Broekhuizen BDL
Prim Care Diabetes; 2018 Feb; 12(1):80-86. PubMed ID: 28919055
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland.
Nicoletti J; Kuster SP; Sulser T; Zbinden R; Ruef C; Ledergerber B; Weber R
Swiss Med Wkly; 2010; 140():w13059. PubMed ID: 20648400
[TBL] [Abstract][Full Text] [Related]
38. Escherichia coli antibiotic resistance in emergency departments. Do local resistance rates matter?
Grignon O; Montassier E; Corvec S; Lepelletier D; Hardouin JB; Caillon J; Batard E;
Eur J Clin Microbiol Infect Dis; 2015 Mar; 34(3):571-7. PubMed ID: 25339200
[TBL] [Abstract][Full Text] [Related]
39. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients.
Sanchez GV; Baird AM; Karlowsky JA; Master RN; Bordon JM
J Antimicrob Chemother; 2014 Dec; 69(12):3259-62. PubMed ID: 25063776
[TBL] [Abstract][Full Text] [Related]
40. Sensitivity of urinary pathogens for patients discharged from the emergency department compared with the hospital antibiogram.
Carlsen S; Krall SP; Xu KT; Tomanec A; Farias D; Richman P
BMC Emerg Med; 2019 Sep; 19(1):50. PubMed ID: 31488057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
